1.5 Abstract in rivista
 Distribuzione geografica
Continente #
NA - Nord America 78.132
AS - Asia 48.088
EU - Europa 29.657
SA - Sud America 29.300
AF - Africa 1.769
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 160
AN - Antartide 2
Totale 187.292
Nazione #
US - Stati Uniti d'America 76.548
BR - Brasile 26.103
SG - Singapore 19.043
CN - Cina 15.514
UA - Ucraina 10.165
DE - Germania 4.309
SE - Svezia 4.277
HK - Hong Kong 3.934
VN - Vietnam 3.535
FR - Francia 2.664
IT - Italia 2.568
FI - Finlandia 1.764
GB - Regno Unito 1.263
AR - Argentina 1.119
TR - Turchia 818
IN - India 673
BD - Bangladesh 651
RU - Federazione Russa 621
IQ - Iraq 615
MX - Messico 571
EC - Ecuador 543
CA - Canada 524
ZA - Sudafrica 493
UZ - Uzbekistan 461
VE - Venezuela 393
PK - Pakistan 391
MA - Marocco 383
CO - Colombia 320
JP - Giappone 282
BE - Belgio 244
KR - Corea 224
PL - Polonia 221
ES - Italia 209
KE - Kenya 205
PY - Paraguay 196
UY - Uruguay 195
NL - Olanda 188
TN - Tunisia 188
ID - Indonesia 186
PE - Perù 172
CZ - Repubblica Ceca 171
JO - Giordania 171
CL - Cile 165
AZ - Azerbaigian 161
AU - Australia 155
DZ - Algeria 142
AE - Emirati Arabi Uniti 141
AT - Austria 121
NP - Nepal 121
EU - Europa 119
SA - Arabia Saudita 118
KZ - Kazakistan 106
EG - Egitto 105
DO - Repubblica Dominicana 97
OM - Oman 93
PH - Filippine 87
AL - Albania 85
IE - Irlanda 85
RS - Serbia 85
IR - Iran 83
LT - Lituania 81
BO - Bolivia 80
IL - Israele 80
PS - Palestinian Territory 77
RO - Romania 77
JM - Giamaica 74
KG - Kirghizistan 72
PA - Panama 71
LB - Libano 70
HN - Honduras 63
GE - Georgia 60
SN - Senegal 57
BY - Bielorussia 54
CR - Costa Rica 54
BG - Bulgaria 48
BH - Bahrain 45
GR - Grecia 40
NI - Nicaragua 39
AM - Armenia 36
MY - Malesia 36
GT - Guatemala 33
CH - Svizzera 32
XK - ???statistics.table.value.countryCode.XK??? 31
BA - Bosnia-Erzegovina 30
MD - Moldavia 30
AO - Angola 29
NG - Nigeria 29
NZ - Nuova Zelanda 29
PT - Portogallo 29
SK - Slovacchia (Repubblica Slovacca) 29
GA - Gabon 28
KW - Kuwait 28
SY - Repubblica araba siriana 28
BN - Brunei Darussalam 26
CI - Costa d'Avorio 26
QA - Qatar 25
DK - Danimarca 23
HR - Croazia 23
HU - Ungheria 23
NO - Norvegia 23
Totale 186.952
Città #
Dallas 28.029
Singapore 8.938
Chandler 8.735
Jacksonville 6.416
San Jose 4.174
Hong Kong 3.861
Dearborn 3.399
Princeton 3.348
Ashburn 3.136
Nanjing 2.922
Beijing 2.669
São Paulo 1.854
Lauterbourg 1.546
Wilmington 1.376
Ho Chi Minh City 1.271
Nanchang 1.116
Shanghai 1.105
Boardman 1.034
New York 856
Ann Arbor 817
Hanoi 813
Rio de Janeiro 787
Los Angeles 751
Belo Horizonte 711
Shenyang 673
Tianjin 617
Hebei 597
Santa Clara 552
Brasília 506
Changsha 490
Jiaxing 485
Sassari 419
Tashkent 414
Curitiba 379
Porto Alegre 364
Woodbridge 359
Buffalo 307
Campinas 304
Baghdad 297
Munich 295
Kunming 294
Guarulhos 276
Tokyo 263
Jinan 254
Salvador 252
San Francisco 245
Hangzhou 244
Orem 241
Norwalk 239
Brussels 235
Seoul 215
Johannesburg 210
Frankfurt am Main 208
Helsinki 204
Toronto 199
Goiânia 192
Warsaw 188
Guayaquil 184
Ribeirão Preto 182
Rome 180
Fortaleza 179
Nairobi 179
Santo André 164
Istanbul 163
Quito 163
Dhaka 160
Amman 158
Montevideo 156
Baku 152
Guangzhou 152
Manaus 152
Montreal 152
Recife 152
Sorocaba 151
Da Nang 150
Zhengzhou 150
Chennai 149
Caxias do Sul 147
Haiphong 146
São José dos Campos 145
Brooklyn 143
Denver 142
Chicago 140
London 139
Ningbo 138
Atlanta 136
Campo Grande 136
Uberlândia 133
Betim 130
Contagem 130
Stockholm 130
Joinville 128
Osasco 128
São José do Rio Preto 128
Brno 127
Nuremberg 127
Izmir 124
São Bernardo do Campo 122
Lima 121
Lahore 118
Totale 106.967
Nome #
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 349
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 343
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 343
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 338
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 337
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 334
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 328
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 328
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 327
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 326
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 325
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 324
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 319
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 314
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 314
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 310
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 308
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 305
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 296
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 291
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 280
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 3-({[(5-hydroxy-4-oxo-4H-pyran-2- yl)methoxy]carbonyl}amino)propanoate. Synthesis and its complex formation study 276
Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma 269
A possible prognostic role for MSRV in multiple sclerosis. 268
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 266
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 263
Adherence to Acrysof intraocular lenses by organisms causing chronic postoperative endophthalmitis 260
A reappraisal of Multiple Sclerosis risk in Sardinians. 258
Abitudini di igiene orale in studenti universitari della città di Sassari. 250
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 247
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 247
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 241
A Case of Multiple Sclerosis and Hydrosyringomyelia: A Non-Coincidental Association? 240
Adhesion properties of ocular isolates of Staphylococcus epidermidis 238
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 237
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 236
123I FP-CIT SPECT in early Parkinson’s disease 227
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 225
A reappraisal of multiple sclerosis risk among Sardinians. 224
APPLICATION OF 2009/127/EC AND 2009/128/EC DIRECTIVES IN SARDINIA (ITALY): RESULTS ON SPRAYING MACHINES 223
Acquired hepatocerebral degeneration responsive to penicillamine: A case report 223
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 223
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 222
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 220
Akt down regulation by CYP2C9-induced ROS generation mediate dose-dependent cell damage elicited by natural antioxidants in human endothelial cells 217
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 216
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 215
A double-blind European Multicenter Study Evidences envelope protein from Human Endogenous Retrovirus W (MSRV-ENV or Syncytin) in serum from 73% of MS patients without selective clinical inclusion criteria 215
A Proteomic Approach To Characterize A Native Antigen Involved In Autoantibody Response In Multiple Sclerosis By A Structure-Based Designed Glycopeptide 210
Autoinflammatory diseases in Dermatology: a peculiar case of familial mediterranean fever 209
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 209
Abstracts from the IVECCS & EVECC Annual Congresses and the ACVECC VetCOT Veterinary Trauma & Critical Care Conference 2016 208
Application of proximal and remote sensing on precision viticulture in Sardinia (Italy) – Preliminary results 207
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 206
Analysis of fanconi anemia genes in colorectal cancer 205
Accessi alle fratture dell’osso frontale e del basicranio anteriore 204
Analysis of gene expression of ovine pre-implantation embryos derived from in vitro fertilization and parthenogenetic activation 204
Asymmetric color perception in the shopping aisle: some implications for merchandising 203
Anthropological investigation on the remains of “Sa Figu” tomb II (Ittiri- Sassari) early bronze age 201
A new sutureless technique for end-to-end and end-to-side arterial and prosthetic anastomosis 200
First report of grapevine black rot in Sardinia. 198
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 195
Archaeometric analyses on pottery of eneolithic age from central Sardinia. 193
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 193
A portable device for estimating the somatic cell count in sheep milk 193
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 193
Analisi dei risultati a medio termine delle artrodesi strumentate lombari mediante approccio estremo laterale 191
A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE 191
COMPARATIVE STUDY ON THE USE OF A NON-DESTRUCTIVE OPTICAL SENSOR (MULTIPLEX3®) FOR THE MONITORING OF THE ANTHOCYANINS CONTENT IN RED BERRY FRUITS 191
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. 191
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 186
Plasma taurine levels in age-related macular degeneration 183
A NEW SUTURELESS TECNIQUE FOR END-TO-END AND END-TO-SIDE ARTERIAL AND PROSTHETIC ANASTOMOSIS 183
Analisi descrittiva degli incidenti da traffico rilevati presso la A.U.S.L. 1 di Sassari nel periodo 1992-1996. 182
Aesthethic refinements in orthognathic surgery: osteotomy versus implants in malar and chin augmentation 182
99mTc-tetrofosmin SPECT: a useful diagnostic tool in breast cancer (BC) detection 181
Caratteristiche morfologiche del disco intervertebrale lombare umano normale e patologico. 181
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 181
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 181
Acute hyponatremia and neuroleptic malignant syndrome 180
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. 180
A new disease of Erica arborea in Italy caused by Neofusicoccum luteum 180
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 178
Acute respiratory paralysis in arsenic neuropathy following intravenous intoxication 178
Brainstem function in multiple sclerosis (MS): clinical, magnetic resonance imaging (MRI) and neurophysiological follow-up 177
1H NMR-based metabolomic analysis of urine from term and preterm neonates 177
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 176
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 176
Antibiotic resistant H-pylori are extremely common in Sardinia. 176
An ultrastructural study on the variability of interfacial morphology between a self etching system and carious and sclerotic dentin 176
18p deletion syndrome: foetal phenotype and cytogenetic characterization 175
Axillary lymph node dissection in T1a and T1b breast cancer. 175
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 173
Analysis of Vermentino plants with symptoms of chlorotic mottling and leaf deformation disease by molecular test and fluorimetric indices 173
A novel candidate gene in human endometrial cancer at chromosome 10q26 173
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 173
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 173
Cadmium induced effects on morphology of glomerul cells of the rat kidney 172
Basal Expression and Regulation by Pro-Inflammatory Cytokines of Human Endogenous Retroviruses of The W Family in Bood Cell Subpopulations and in Astrocytes. 171
A genome-wide analysis of Sardinian population structure 170
Totale 22.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.495 0 0 0 0 0 0 0 0 0 2.264 747 484
2021/20226.733 958 63 29 64 25 57 263 570 573 304 720 3.107
2022/202317.146 1.817 782 257 2.886 1.939 2.940 23 2.074 3.047 142 793 446
2023/20244.968 920 396 252 181 974 399 62 164 3 109 550 958
2024/202549.954 478 391 2.799 775 1.642 1.340 3.096 11.715 18.038 6.657 1.751 1.272
2025/202667.646 2.530 19.792 11.419 9.919 4.962 3.548 8.641 2.133 3.068 1.634 0 0
Totale 188.275